Tabilautide

This classification denotes a biological response modifier, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) EZ61NB05TG. European Medicines Agency schedules Tabilautide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10793MIG. Tabilautide generally arises in the molecular formula C27H49N5O8. The term TABILAUTIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, list 29.) TABILAUTIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule tabilautide under HS 29241900 and SITC 51471. As of Q4 2014, TABILAUTIDE remains US FDA's Preferred Term for this commodity. Tabilautide bears US NLM identifiers UMLS ID C2699878 and NCI Concept Code C76570. SMILES: O=C(NC(C(=O)NC(CCC(=O)NC(CCCC(N)C(=O)N)C(=O)O)C(=O)O)C)CCCCCCCCCCC.